Nurami Overview

  • Founded
  • 2014

Founded
  • Status
  • Private

  • Employees
  • 6

Employees
  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $6M

  • Investors
  • 10

Nurami General Information

Description

Developer of biomaterials and nanofiber-based matrix intended to improve patient outcomes in various surgical procedures. The company's matrices combine porous scaffold for tissue regeneration enhancement with a novel temperature-sensitive sealant to prevent the entry of pathogens and CSF leaks, enabling surgeons to seamlessly answer the unmet needs of their patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Surgical Devices
Other Industries
Drug Discovery
Primary Office
  • 36 Ha-Namal Street
  • Post Office Box 33964
  • Haifa 3303203
  • Israel
+972 000-000-0000

Nurami Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nurami Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series B) 02-Nov-2020 $6M 00.00 000.00 Completed Clinical Trials - General
5. Grant 01-Dec-2019 00000 00.000 Completed Generating Revenue
4. Early Stage VC (Series A) 01-Jul-2018 000 00.000 Completed Generating Revenue
3. Grant 01-Dec-2017 00000 00.000 Completed Generating Revenue
2. Seed Round 20-Dec-2016 $1.74M $1.74M 00.000 Completed Generating Revenue
1. Grant $882K Completed Startup
To view Nurami’s complete valuation and funding history, request access »

Nurami Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Preferred A 000,000 0000.00 0000.00 00 0000.00 00.000
Ordinary A 0,000,000 000.00 000.00 00 000.00 00.000
To view Nurami’s complete cap table history, request access »

Nurami Patents

Nurami Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3802111-A1 An adhesive layered matrix and uses thereof Pending 27-May-2018 00000000
US-20210252186-A1 An adhesive layered matrix and uses thereof Pending 27-May-2018 00000000
CA-3100437-A1 An adhesive layered matrix and uses thereof Pending 27-May-2018 00000000
EP-3083233-A1 A tissue substitute multilayer matrix and uses thereof Granted 17-Dec-2013 000000000
US-20200078488-A1 Tissue substitute multilayer matrix and uses thereof Pending 17-Dec-2013 A61L15/26
To view Nurami’s complete patent history, request access »

Nurami Executive Team (4)

Name Title Board Seat Contact Info
Nora Nseir Co-Founder, Co-Chief Executive Officer and Chief Technology Officer
Hannoch Marksheid Ph.D Co-Chief Executive Officer & Business Development Manager
Nizar Mishael Chief Financial Officer
Amir Bahar Ph.D Co-Founder & Chief Operating Officer
To view Nurami’s complete executive team members history, request access »

Nurami Board Members (2)

Name Representing Role Since
Doron Birger Self Chairman 000 0000
Zohar Gendler Next Generation Technology Board Member 000 0000
To view Nurami’s complete board members history, request access »

Nurami Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nurami Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Almeda Ventures Venture Capital Minority 000 0000 000000 0
GlenRock Israel Growth/Expansion Minority 000 0000 000000 0
Jacobs Investments Family Office Minority 000 0000 000000 0
Ratio technologies (Israel) Venture Capital Minority 000 0000 000000 0
Beijing BASIBA Biomedical Engineering Science & Technology Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »